Actinium Pharmaceuticals reported 81K in Gross Profit on Sales for its fiscal quarter ending in December of 2023.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Actinium Pharmaceuticals 81K 36K Dec/2023
Amgen USD 6.48B 307M Sep/2025
Bioline Rx USD 343K 111K Sep/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Pfizer USD 3.54B 7.61B Sep/2025